New 91自拍 from the 91自拍 examines the behavior of prescription opioid companies following key events in Kentucky鈥檚 lawsuit against Purdue Pharma regarding its controlled-release oral formulation of oxycodone hydrochloride (OxyContin). While Purdue Pharma significantly decreased its marketing budget for OxyContin, the UW 91自拍ers found that Kentucky’s litigation had the opposite effect on competing companies, with those companies marketing opioids to physicians previously pursued by Purdue Pharma, including in counties where the opioid crisis was known to be severe….
UW 91自拍 finds pharma companies increased opioids marketing after Purdue Pharma lawsuit









